PMID- 26107131
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150626
LR  - 20240124
IS  - 2162-0989 (Print)
IS  - 2162-0989 (Linking)
VI  - 1
IP  - 2
DP  - 2012 Mar-Apr
TI  - An Update in Laser and Pharmaceutical Treatment for Polypoidal Choroidal 
      Vasculopathy.
PG  - 97-104
LID - 10.1097/APO.0b013e31823e5a95 [doi]
AB  - Polypoidal choroidal vasculopathy (PCV) is a condition characterized by multiple, 
      recurrent, serosanguineous pigment epithelium detachment and neurosensory retinal 
      detachment due to abnormal choroidal polypoidal lesions. Polypoidal choroidal 
      vasculopathy is particularly prevalent in Asians and occurs in up to 30% of 
      patients presenting with neovascular age-related macular degeneration. In recent 
      years, various treatment modalities have been described in the literature for the 
      treatment of PCV. This review article aims to provide an overview and to 
      summarize the current nonsurgical treatment for PCV.
FAU - Lai, Timothy Y Y
AU  - Lai TY
AD  - From the *Department of Ophthalmology & Visual Sciences, The Chinese University 
      of Hong Kong; dagger2010 Retina and Macula Centre, Kowloon; and double daggerDepartment of 
      Ophthalmology, Hong Kong Sanatorium and Hospital, Hong Kong.
FAU - Chan, Wai-Man
AU  - Chan WM
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Asia Pac J Ophthalmol (Phila)
JT  - Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
JID - 101583622
EDAT- 2012/03/01 00:00
MHDA- 2012/03/01 00:01
CRDT- 2015/06/25 06:00
PHST- 2015/06/25 06:00 [entrez]
PHST- 2012/03/01 00:00 [pubmed]
PHST- 2012/03/01 00:01 [medline]
AID - S2162-0989(23)00856-3 [pii]
AID - 10.1097/APO.0b013e31823e5a95 [doi]
PST - ppublish
SO  - Asia Pac J Ophthalmol (Phila). 2012 Mar-Apr;1(2):97-104. doi: 
      10.1097/APO.0b013e31823e5a95.